CRANBURY, N.J.--The American Journal of Managed Care® (AJMC®) presents Dr. Shantanu Agrawal and Clay Alspach as the featured speakers for the upcoming ACO & Emerging Healthcare Delivery Coalition® fall 2017 meeting on October 26-27 at the Sheraton Grand Nashville Downtown in Nashville, Tennessee.
“Both Dr. Agrawal and Alspach bring unique insights from the world of healthcare policies and management. We aim to offer the audience the utmost understanding of the evolution in our country’s healthcare model.” said Jeff Prescott, PharmD, senior vice president of Managed Markets.
Shantanu Agrawal, MD, MPhil, president and chief executive officer of the National Quality Forum, will deliver the plenary presentation on the first day of the meeting. Dr. Agrawal is a board-certified emergency medicine physician who has played a vital role in the evolution of U.S. healthcare policies and initiatives, including improving physician experience and value of care, and tackling the opioid epidemic. He is the former deputy administrator of the Centers for Medicare & Medicaid Services and former director of its Center for Program Integrity, during the Obama administration.
The second day’s plenary presentation will be delivered by Clay Alspach, principal at Leavitt Partners in Washington, D.C. Alspach specializes in healthcare policy and advocacy related to the Food and Drug Administration, health information technology, Medicare, and Medicaid; he is able to address the Affordable Care Act repeal and replace efforts both from political and procedural perspectives. Previously, he served as the chief health counsel for Rep. Fred Upton (R-Michigan), chairman of the U.S. House of Representatives Energy and Commerce Committee.
To register for this event, visit http://www.ajmc.com/acocoalition/fall17#register.
About The American Journal of Managed Care®
The American Journal of Managed Care® (AJMC®) is a peer-reviewed, MEDLINE-indexed journal that keeps readers on the forefront of health policy by publishing research relevant to industry decision makers as they work to promote the efficient delivery of high-quality care. AJMC.com is the essential website for managed care professionals, distributing industry updates daily to leading stakeholders. Other titles in the AJMC® family include The American Journal of Accountable Care®, Evidence-Based Oncology™ and Evidence-Based Diabetes Management™. These comprehensive offerings bring together stakeholder views from payers, providers, policymakers, and other industry leaders in managed care. To order reprints of articles appearing in AJMC® publications, please contact Dr. Jeff Prescott at (609) 716-7777, x331.
Contacts
AJMC® Media
Theresa Burek
tburek@mjhassoc.com
or
Surabhi Verma
sverma@mjhassoc.com
Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD
July 8th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, while bispecific antibodies are reserved for later lines or for patients unable to tolerate CAR T.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Driving Value via Outcomes-Based Pricing and EHR Interoperability: Tyler Sandahl, PharmD
July 7th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, discussed the complexities of alternative payment models for chimeric antigen receptor T-cell and bispecific therapies and the need for improved data sharing in cancer care.
Read More
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More